Fig. 2

Description of symptoms and prevalence of the subvariant. (A) Percentage of symptoms compared to breakthrough infection and reinfection during SARS-CoV-2 infection. (B) The prevalence of SARS-CoV-2 at different times for all individuals. “Others” represents the occurrence of symptoms not shown in the figure. *: <0.05, **: <0.01, ***: <0.001, ****: <0.0001.